Whether to prescribe the embattled agent is the question. What's your answer?
FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes
The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
GLP-1RAs Cut Early Colorectal Cancer Risk in Adults with T2D: Daily Dose
Your daily dose of the clinical news you may have missed.
Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.
Semaglutide May Reduce Alzheimer’s Risk in Adults with T2D: Daily Dose
Oral Semaglutide Linked to Lower Risk of MACE: Daily Dose
